BBOT
BridgeBio Oncology Therapeutics, Inc. (BBOT)
Market Closed
12 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
12. 54
-0.29
-2.3%
$
- Market Cap
- P/E Ratio
- Div Yield
115,308 Volume
- Eps
$ 12.84
Previous Close Day Range
12.21 13.02
Year Range
8.5 14.87
Want to track BBOT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 60 days
Summary
BBOT closed today lower at $12.54, a decrease of 2.3% from yesterday's close, completing a monthly increase of 0% or $12.54. Over the past 12 months, BBOT stock gained 0%.
BBOT is not paying dividends to its shareholders.
The last earnings report, released on Nov 12, 2025, missed the consensus estimates by -0.69%. On average, the company has fell short of earnings expectations by -0.69%, based on the last three reports. The next scheduled earnings report is due on Feb 11, 2026.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on NASDAQ (NMS) (USD).
BBOT Chart
BridgeBio Oncology Therapeutics: Promising KRAS Drug Developer - In My View, At Least
BridgeBio Oncology Therapeutics (BBOT) targets KRAS and PI3Ka malignancies with next-generation small molecule therapeutics, aiming to surpass current market leaders. BBOT's lead candidate, BBO-8520, demonstrated a strong overall response rate in early Phase 1a data for KRAS G12C NSCLC, with no Grade 2+ adverse events. All three BBOT pipeline candidates are expected to report Phase 1 data in 2026, positioning the company for key clinical catalysts.
Seekingalpha | 10 hours ago
BridgeBio Oncology Therapeutics, Inc. (BBOT) FAQ
What is the stock price today?
The current price is $12.54.
On which exchange is it traded?
BridgeBio Oncology Therapeutics, Inc. is listed on NASDAQ (NMS).
What is its stock symbol?
The ticker symbol is BBOT.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
When is the next earnings date?
The next earnings report will release on Feb 11, 2026.
Has BridgeBio Oncology Therapeutics, Inc. ever had a stock split?
No, there has never been a stock split.
2025 © Marketlog. All Rights Reserved.
